Teva Pharmaceuticals

Parsippany, NJ ManufacturingNAICS 325410

Self-funded health planPlan year 2025Renews January
5,302Participants+3% vs. prior year
$12.6MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#14 of 76Manufacturing in NJBy participants

Overview

Teva Pharmaceuticals sponsors a self-funded health plan that covered 5,302 participants in plan year 2025, up 3% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
5,302 · prior year 5,156
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Teva Pharmaceuticals USA, Inc. Omnibus Welfare Benefit Plan, plan 509 (5,302 participants)
Broker compensation
$870K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityLong-term disabilitySeveranceDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Reliance Standard Life Insurance CompanyAccidental Death and Dismemberment, Hospital Indemnity, Life, Long-term disability4,955$4.3M$465K
Aetna Life Insurance Co.PPO, Dental4,811$1.0M$187K
Provident Life and Accident Insurance CompanyLife, Short-term disability292$538K$213K
Health and Human Resource CenterEmployee Assistance Program92$2K—

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$12.6M/ year

Estimated prescription spend: 5,302 participants × $2,371 national average per member. Usually higher once dependents are counted.

$327K–$806K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$96K–$239K
Lower-cost therapeutic alternatives$140K–$292K
Generic pricing vs. actual cost$60K–$181K
PBM contract terms$31K–$94K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Teva Pharmaceuticals
Sponsor EIN
22-1734359
Plan number
509
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 22-1734359 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Teva Pharmaceuticals Retirement Savings Plan
Type
401(k) plan
Participants
9,752

About this data

Source: Teva Pharmaceuticals's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Teva Pharmaceuticals.

Request a correction · Methodology